HALF-YEAR REPORT

30 JUNE 2022

2022 Half-Year-Report SHOP APOTHEKE EUROPE     ABOUT SHOP APOTHEKE.

2

ABOUT SHOP APOTHEKE.

SHOP APOTHEKE EUROPE is one of Europe's leading and fastest-growing online pharmacies, currently operating in Germany, Austria, France, Belgium, Italy, the Netherlands and Switzerland.

We are evolving our business by developing SHOP APOTHEKE EUROPE from an online retailer to a customer-centrice-pharmacy platform, which will open new revenue and margin streams for the company. With last year's two acquisitions of the digital medication management experts SMARTPATIENT and MEDAPP we have reached further important milestones of our strategy - also in preparation for the anticipated upcoming large e-Rx business.

Headquartered in the Dutch logistics hub of Sevenum near Venlo with locations in Cologne, Berlin, Munich (Germany), Eindhoven (the Netherlands), Tongeren (Belgium), Lille (France), Milan (Italy) and Warsaw (Poland), SHOP APOTHEKE EUROPE offers its customers a broad range of more than 100,000 original products at attractive prices: OTC, beauty and personal care products as well as prescription drugs, supplemented by high quality natural food and health products, low carb products and sports nutrition. Currently, more than 8.5 million active customers trust

SHOP APOTHEKE EUROPE.

In addition, SHOP APOTHEKE EUROPE provides comprehensive pharmaceutical consulting services and last mile delivery options in certain of its georgraphies, for example with local third-party pharmacy partners. Last December, the company extended its product portfolio to additional healthcare-related products with the launch of its own marketplace in Germany and rolled this out further into Europe with the opening of the marketplace in Austria in Q2 2022. This assortment is sold directly from our third-party partners to customers.

SHOP APOTHEKE EUROPE N.V. has been listed on the regulated market of the Frankfurt Stock Exchange (Prime Standard) since 2016.

2022 Half-Year-Report SHOP APOTHEKE EUROPE      Table of contents.

3

TABLE OF CONTENTS.

01INTERIM GROUP MANAGEMENT REPORT.

OVERALL ASSESSMENT BY THE MANAGEMENT BOARD.

6

OVERALL ECONOMIC SITUATION.

6

BUSINESS MODEL, GROUP STRUCTURE AND CORPORATE GOVERNANCE.

7

BUSINESS DEVELOPMENT.

7

SEGMENT PERFORMANCE.

10

ASSETS, LIABILITIES AND FINANCIAL POSITION.

12

RISKS AND OPPORTUNITIES.

13

IMPORTANT EVENTS DURING THE REPORTING PERIOD.

13

EVENTS AFTER THE BALANCE SHEET DATE.

13

FORECAST.

13

02

APPENDIX.

CONSOLIDATED STATEMENT OF PROFIT AND LOSS.

15

STATEMENT OF COMPREHENSIVE INCOME.

16

CONSOLIDATED STATEMENT OF FINANCIAL POSITION.

17

CONSOLIDATED STATEMENT OF CASH FLOWS.

18

CONSOLIDATED INTERIM STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY.

19

SEGMENT INFORMATION.

20

BUSINESS COMBINATIONS.

24

NOTES TO THE CONSOLIDATED INTERIM FINANCIAL STATEMENTS.

26

CONTACT.

29

This interim financial report does not include all the notes of the type normally included in an annual financial report. Accordingly, this report should be read in conjunction with the annual report for the year ended 31 December 2021 and any public announcements made by SHOP APOTHEKE EUROPE N.V. during the interim reporting period.

2022 Half-Year-Report SHOP APOTHEKE EUROPE      Highlights.

4

KEY FIGURES.

Continuously increasing our strong growth across Europe.

REVENUE H1:

PARCELS SENT IN H1:

EUR 592 MILLION (+ 11 %).

> 65,000 PARCELS A DAY.

GROSS MARGIN:

REPEAT ORDERS H1:

INCREASED TO 27.2%.

82 PERCENT.

ACTIVE CUSTOMERS:

AVERAGE SHOPPING

8.6 MILLION.

BASKET SIZE:

+ 0.8 MILLION CUSTOMERS

€ 57.3 (H1 2021: € 62.6).

IN H1.

SITE VISITS H1:

CUSTOMER SATISFACTION:

178.9 MILLION (+ 29 %).

NET PROMOTER SCORE (NPS)

OF 73.

01INTERIM GROUP MANAGEMENT REPORT.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Shop Apotheke Europe NV published this content on 03 August 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 03 August 2022 07:21:15 UTC.